Literature DB >> 15024756

Rat brain vascular distribution of interleukin-1 type-1 receptor immunoreactivity: relationship to patterns of inducible cyclooxygenase expression by peripheral inflammatory stimuli.

Jan Pieter Konsman1, Stephan Vigues, Ludmila Mackerlova, Adrian Bristow, Anders Blomqvist.   

Abstract

Interleukin-1 beta (IL-1 beta) is thought to act on the brain to induce fever, neuroendocrine activation, and behavioral changes during disease through induction of prostaglandins at the blood-brain barrier (BBB). However, despite the fact that IL-1 beta induces the prostaglandin-synthesizing enzyme cyclooxygenase-2 (COX-2) in brain vascular cells, no study has established the presence of IL-1 receptor type 1 (IL-1R1) protein in these cells. Furthermore, although COX inhibitors attenuate expression of the activation marker c-Fos in the preoptic and paraventricular hypothalamus after administration of IL-1 beta or bacterial lipopolysaccharide (LPS), they do not alter c-Fos induction in other structures known to express prostaglandin receptors. The present study thus sought to establish whether IL-1R1 protein is present and functional in the rat cerebral vasculature. In addition, the distribution of IL-1R1 protein was compared to IL-1 beta- and LPS-induced COX-2 expression. IL-1R1-immunoreactive perivascular cells were mostly found in choroid plexus and meninges. IL-1R1-immunoreactive vessels were seen throughout the brain, but concentrated in the preoptic area, subfornical organ, supraoptic hypothalamus, and to a lesser extent in the paraventricular hypothalamus, cortex, nucleus of the solitary tract, and ventrolateral medulla. Vascular IL-1R1-ir was associated with an endothelial cell marker, not found in arterioles, and corresponded to the induction patterns of phosphorylated c-Jun and inhibitory-factor kappa B mRNA upon IL-1 beta stimulation, and colocalized with peripheral IL-1 beta- or LPS-induced COX-2 expression. These observations indicate that functional IL-1R1s are expressed in endothelial cells of brain venules and suggest that vascular IL-1R1 distribution is an important factor determining BBB prostaglandin-dependent activation of brain structures during infection. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15024756     DOI: 10.1002/cne.20052

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  74 in total

1.  Expression and localization of p80 interleukin-1 receptor protein in the rat spinal cord.

Authors:  Xiao-Fei Wang; Lan Yin; Jian-Guo Hu; Li-Dong Huang; Pan-Pan Yu; Xiao-Yan Jiang; Xiao-Ming Xu; Pei-Hua Lu
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

Review 2.  Cytokine, sickness behavior, and depression.

Authors:  Robert Dantzer
Journal:  Neurol Clin       Date:  2006-08       Impact factor: 3.806

Review 3.  A systematic review of the association between immunogenomic markers and cancer-related fatigue.

Authors:  L N Saligan; H S Kim
Journal:  Brain Behav Immun       Date:  2012-05-14       Impact factor: 7.217

4.  Expression patterns and action analysis of genes associated with hepatitis virus infection during rat liver regeneration.

Authors:  Li-Juan Su; Guang-Wei Ding; Zhi-Li Yang; Shou-Bing Zhang; Yu-Xiu Yang; Cun-Shuan Xu
Journal:  World J Gastroenterol       Date:  2006-12-21       Impact factor: 5.742

Review 5.  Immune-to-brain signaling: how important are the blood-brain barrier-independent pathways?

Authors:  Ning Quan
Journal:  Mol Neurobiol       Date:  2008-06-19       Impact factor: 5.590

6.  Transport of interleukin-1 across cerebromicrovascular endothelial cells.

Authors:  R A Skinner; R M Gibson; N J Rothwell; E Pinteaux; J I Penny
Journal:  Br J Pharmacol       Date:  2009-03-04       Impact factor: 8.739

7.  Early manifestation of mild cognitive impairment in B-cell non-Hodgkin's lymphoma patients receiving CHOP and rituximab-CHOP chemotherapy.

Authors:  Mohd Ashif Khan; Kamlesh Garg; Dinesh Bhurani; Nidhi Bharal Agarwal
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-08-27       Impact factor: 3.000

8.  Neurobiology of inflammation-associated anorexia.

Authors:  Laurent Gautron; Sophie Layé
Journal:  Front Neurosci       Date:  2010-01-08       Impact factor: 4.677

9.  Evolving refractory major depressive disorder diagnostic and treatment paradigms: toward closed-loop therapeutics.

Authors:  Matthew P Ward; Pedro P Irazoqui
Journal:  Front Neuroeng       Date:  2010-05-31

10.  Preliminary evidence of an association between an interleukin 6 promoter polymorphism and self-reported attentional function in oncology patients and their family caregivers.

Authors:  John D Merriman; Bradley E Aouizerat; Dale J Langford; Bruce A Cooper; Christina R Baggott; Janine K Cataldo; Anand Dhruva; Laura Dunn; Claudia West; Steven M Paul; Christine S Ritchie; Patrick S Swift; Christine Miaskowski
Journal:  Biol Res Nurs       Date:  2013-03-11       Impact factor: 2.522

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.